This site is intended for healthcare professionals only

Patients in Scotland lack access to cancer drugs

Written by: | Published:

More than a third of oncologists and haematologists in Scotland are aware of cancer patients relocating England for 'better' treatment.

According to a study of 28 consultants by research firm Aldelphi, funded by pharmaceutical company Roche, nearly all (96 per cent) consider access to cancer therapies to be 'better' in England than Scotland, with half saying restricted access has lowered Scotland's standard of care compared to the rest of Europe.

Cancer clinicians list 34 drugs rejected by the Scottish Medicines Consortium to which they would like better access.

In January, the Scottish Government launched a £21m Rare Conditions Medicines Fund but it is not clear if this will be available for cancer medicines.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.



Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code

Read a free issue from Practice Nursing

Register to read a free issue from our sister publication, Practice Nursing.

Including articles on asthma, diabetes and more. Read your copy.


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.